Publications by authors named "Amos Adapalala Bugri"
Objective: There is a need to assess the quality of antimicrobial prescribing in hospitals as a first step toward improving future prescribing to reduce antimicrobial resistance (AMR). This is in line with Ghana's National Action Plan.
Methods: A point prevalence survey of antimicrobial use was undertaken at the adult medical, surgical, and pediatric wards of Tamale Teaching Hospital using the standardized Global Point Prevalence Survey (GPPS) tool.
Prevalence of Hypertensive Disorders, Antihypertensive Therapy and Pregnancy Outcomes among Pregnant Women: A Retrospective Review of Cases at Tamale Teaching Hospital, Ghana.
Amos Adapalala Bugri Solomon Kwabena Gumanga Peter Yamoah Ebenezer Kwabena Frimpong Manimbulu Nlooto
Int J Environ Res Public Health
June 2023
Article Synopsis
- Hypertensive disorders during pregnancy are a significant health issue, with the study revealing a prevalence rate of 12.5% among pregnant women at Tamale Teaching Hospital in Ghana from June 2018 to May 2019.
- The most frequently prescribed antihypertensive medication was sustained-release oral nifedipine, used by 81.4% of participants, while a notable percentage of babies (5.7%) died before delivery, primarily among mothers with high blood pressure.
- The study indicated a strong link between blood pressure management and positive delivery outcomes, suggesting effective adherence to Ghana's treatment guidelines, as about two-thirds of participants had well-controlled blood pressure, leading to better results for both mothers and babies.
Article Synopsis
- Tuberculosis (TB) is a significant health issue, particularly in developing countries, and although treatment is effective, adverse drug reactions (ADRs) can lead to poor adherence and increased therapy failure rates.
- A study conducted over six months in Tamale Teaching Hospital involved 66 participants on first-line antituberculotic therapy, using questionnaires for data collection and SPSS for analysis.
- Results showed that 77% of participants experienced ADRs, mainly gastrointestinal symptoms, and more than half reported that these reactions affected their medication adherence, with many skipping doses or stopping treatment altogether.